You are here

Article Text

Article menu
Download PDFPDF
Featured editorial
Evolution of the definition of myocardial infarction: what are the implications of a new universal definition?

https://doi.org/10.1136/hrt.2007.130955

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Funding: Research Grants>$10 000 from: Sanofi Aventis, Eli Lilly, Merck Sharpe & Dohme, Medicines Company, Neuren Pharmaceuticals, NIH, GlaxoSmithKline, Pfizer, Roche, Fournier Laboratories, Johnson & Johnson, Schering Plough, Janssen-Cilag; Consulting Fees: Medicure<$10 000, Medicines Company<$10 000, Neuren Pharmaceuticals<$10 000, GlaxoSmithKline<$10 000, Bayer<$10 000, Sanofi Aventis<$10 000; Speaker’s Honorarium: Sanofi Aventis<$10 000.

    • Competing interests: None.